{"id":8176,"date":"2025-06-06T08:58:44","date_gmt":"2025-06-06T08:58:44","guid":{"rendered":"https:\/\/blog.mygenericpharmacy.com\/?p=8176"},"modified":"2025-06-06T08:58:49","modified_gmt":"2025-06-06T08:58:49","slug":"combo-therapy-may-cut-stage-3-colon-cancer-recurrence-death-risk-by-50","status":"publish","type":"post","link":"https:\/\/blog.mygenericpharmacy.com\/index.php\/2025\/06\/06\/combo-therapy-may-cut-stage-3-colon-cancer-recurrence-death-risk-by-50\/","title":{"rendered":"Combo therapy may cut stage 3 colon cancer recurrence, death risk by 50%"},"content":{"rendered":"\n<p>Exciting news in oncology! A recent study suggests that <strong>combo therapy<\/strong> (likely combining chemotherapy with other treatments like immunotherapy or targeted therapy) may reduce the risk of <strong>recurrence and death in stage 3 colon cancer by up to 50%<\/strong> compared to standard treatments alone.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Key Points:<\/strong><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Stage 3 colon cancer<\/strong> means the cancer has spread to nearby lymph nodes but not distant organs.<\/li>\n\n\n\n<li>Current standard treatment is <strong>surgery + chemotherapy<\/strong> (e.g., FOLFOX or CAPOX).<\/li>\n\n\n\n<li>The new <strong>combo therapy<\/strong> (exact drugs not specified here) appears to significantly improve outcomes.<\/li>\n\n\n\n<li>A <strong>50% reduction in recurrence and death risk<\/strong> is a major breakthrough if confirmed in larger trials.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Why This Matters:<\/strong><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Colon cancer recurrence is a major concern; preventing it improves survival.<\/li>\n\n\n\n<li>If validated, this could become a new <strong>standard of care<\/strong> for high-risk patients.<\/li>\n<\/ul>\n\n\n\n<p><strong>Reference:<\/strong><\/p>\n\n\n\n<p><a href=\"https:\/\/www.targetedonc.com\/view\/atezolizumab-chemo-reduces-risk-of-recurrence-or-death-by-50-in-dmmr-colon-cancer\">https:\/\/www.targetedonc.com\/view\/atezolizumab-chemo-reduces-risk-of-recurrence-or-death-by-50-in-dmmr-colon-cancer<\/a><\/p>\n\n\n\n<p><a href=\"https:\/\/www.medicalnewstoday.com\/articles\/combo-immunotherapy-may-cut-stage-3-colon-cancer-recurrence-death-rate-50-percent\">https:\/\/www.medicalnewstoday.com\/articles\/combo-immunotherapy-may-cut-stage-3-colon-cancer-recurrence-death-rate-50-percent<\/a><\/p>\n\n\n\n<p><a href=\"https:\/\/newsnetwork.mayoclinic.org\/discussion\/immunotherapy-boosts-chemotherapy-in-combating-stage-3-colon-cancer\">https:\/\/newsnetwork.mayoclinic.org\/discussion\/immunotherapy-boosts-chemotherapy-in-combating-stage-3-colon-cancer<\/a><\/p>\n\n\n\n<p><a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3126021\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3126021<\/a><\/p>\n\n\n\n<p>Medications that have been suggested by doctors worldwide are available on below link<\/p>\n\n\n\n<p><a href=\"https:\/\/mygenericpharmacy.com\/category\/disease\/cancer\">https:\/\/mygenericpharmacy.com\/category\/disease\/cancer<\/a><\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Exciting news in oncology! A recent study suggests that combo therapy (likely combining chemotherapy with other treatments like immunotherapy or targeted therapy) may reduce the risk of recurrence and death in stage 3 colon cancer by up to 50% compared to standard treatments alone. Key Points: Why This Matters: Reference: https:\/\/www.targetedonc.com\/view\/atezolizumab-chemo-reduces-risk-of-recurrence-or-death-by-50-in-dmmr-colon-cancer https:\/\/www.medicalnewstoday.com\/articles\/combo-immunotherapy-may-cut-stage-3-colon-cancer-recurrence-death-rate-50-percent https:\/\/newsnetwork.mayoclinic.org\/discussion\/immunotherapy-boosts-chemotherapy-in-combating-stage-3-colon-cancer https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3126021 Medications that have been suggested by doctors worldwide are available on below link https:\/\/mygenericpharmacy.com\/category\/disease\/cancer<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[909],"tags":[],"class_list":["post-8176","post","type-post","status-publish","format-standard","hentry","category-cancer"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/blog.mygenericpharmacy.com\/index.php\/wp-json\/wp\/v2\/posts\/8176","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blog.mygenericpharmacy.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blog.mygenericpharmacy.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blog.mygenericpharmacy.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/blog.mygenericpharmacy.com\/index.php\/wp-json\/wp\/v2\/comments?post=8176"}],"version-history":[{"count":1,"href":"https:\/\/blog.mygenericpharmacy.com\/index.php\/wp-json\/wp\/v2\/posts\/8176\/revisions"}],"predecessor-version":[{"id":8177,"href":"https:\/\/blog.mygenericpharmacy.com\/index.php\/wp-json\/wp\/v2\/posts\/8176\/revisions\/8177"}],"wp:attachment":[{"href":"https:\/\/blog.mygenericpharmacy.com\/index.php\/wp-json\/wp\/v2\/media?parent=8176"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blog.mygenericpharmacy.com\/index.php\/wp-json\/wp\/v2\/categories?post=8176"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blog.mygenericpharmacy.com\/index.php\/wp-json\/wp\/v2\/tags?post=8176"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}